Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 32: 146-152, 1986;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lapidus, L.
Right arrow Articles by Gredmark, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lapidus, L.
Right arrow Articles by Gredmark, T.

Clinical Chemistry, Vol 32, 146-152, Copyright © 1986 by American Association for Clinical Chemistry

Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women

L Lapidus, G Lindstedt, PA Lundberg, C Bengtsson and T Gredmark

We determined sex-hormone binding globulin (SHBG) and corticosteroid binding globulin (CBG) by radioimmunoassay of serum samples from a group of 253 women, who were 54 or 60 years old when first studied in 1968-69. The SHBG concentration was highly significantly and inversely related to body mass, body mass index, waist-to-hip circumference ratio, and serum triglyceride concentration; CBG concentration was inversely related to body mass and body mass index. The concentration of neither protein was related to whether or not the subject smoked. Decrease in the concentration of SHBG, but not of CBG, was a significant risk factor for 12-year overall mortality. The plot of the 12-year incidence of myocardial infarction vs SHBG concentration was U- shaped. We recommend that SHBG be included when serum androgens or estrogens are being evaluated as risk factors for cardiovascular disease and death.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Endocrinol. Metab.Home page
N. Xita and A. Tsatsoulis
Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1660 - 1666.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
E. S. Ford and S. Liu
Invited Commentary: Acne in Adolescence--Protecting the Heart but Damaging the Prostate Later in Life?
Am. J. Epidemiol., June 15, 2005; 161(12): 1102 - 1106.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Z. Ring, C. N. Lessov, T. Reed, R. Marcus, L. Holloway, G. E. Swan, and D. Carmelli
Heritability of Plasma Sex Hormones and Hormone Binding Globulin in Adult Male Twins
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3653 - 3658.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Sutton-Tyrrell, R. P. Wildman, K. A. Matthews, C. Chae, B. L. Lasley, S. Brockwell, R. C. Pasternak, D. Lloyd-Jones, M. F. Sowers, J. I. Torrens, et al.
Sex Hormone-Binding Globulin and the Free Androgen Index Are Related to Cardiovascular Risk Factors in Multiethnic Premenopausal and Perimenopausal Women Enrolled in the Study of Women Across the Nation (SWAN)
Circulation, March 15, 2005; 111(10): 1242 - 1249.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Kalme, M. Seppala, Q. Qiao, R. Koistinen, A. Nissinen, M. Harrela, M. Loukovaara, P. Leinonen, and J. Tuomilehto
Sex Hormone-Binding Globulin and Insulin-Like Growth Factor-Binding Protein-1 as Indicators of Metabolic Syndrome, Cardiovascular Risk, and Mortality in Elderly Men
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1550 - 1556.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Cousin, L. Calemard-Michel, H. Lejeune, G. Raverot, N. Yessaad, A. Emptoz-Bonneton, Y. Morel, and M. Pugeat
Influence of SHBG Gene Pentanucleotide TAAAA Repeat and D327N Polymorphism on Serum Sex Hormone-Binding Globulin Concentration in Hirsute Women
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 917 - 924.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Xita, A. Tsatsoulis, A. Chatzikyriakidou, and I. Georgiou
Association of the (TAAAA)n Repeat Polymorphism in the Sex Hormone-Binding Globulin (SHBG) Gene with Polycystic Ovary Syndrome and Relation to SHBG Serum Levels
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5976 - 5980.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. M. Rexrode, J. E. Manson, I-M. Lee, P. M Ridker, P. M. Sluss, N. R. Cook, and J. E. Buring
Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women
Circulation, October 7, 2003; 108(14): 1688 - 1693.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P.-H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, M. Laville, and M. Pugeat
Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3626 - 3631.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Q. Dai, A. A. Franke, H. Yu, X.-o. Shu, F. Jin, J. R. Hebert, L. J. Custer, Y.-T. Gao, and W. Zheng
Urinary Phytoestrogen Excretion and Breast Cancer Risk: Evaluating Potential Effect Modifiers Endogenous Estrogens and Anthropometrics
Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 497 - 502.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Joyner, L. J. Hutley, A. W. Bachmann, D. J. Torpy, and J. B. Prins
Greater replication and differentiation of preadipocytes in inherited corticosteroid-binding globulin deficiency
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1049 - E1054.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, M. Pugeat, M. Grasa, M. Broch, J. Vendrell, J. Brun, and W. Ricart
Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4686 - 4690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Janne and G. L. Hammond
Hepatocyte Nuclear Factor-4 Controls Transcription from a TATA-less Human Sex Hormone-binding Globulin Gene Promoter
J. Biol. Chem., December 18, 1998; 273(51): 34105 - 34114.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Andersson, L.-A. Mattsson, L. Hahn, L. Lapidus, G. Holm, B.-A. Bengtsson, and P. Bjorntorp
Estrogen Replacement Therapy Decreases Hyperandrogenicity and Improves Glucose Homeostasis and Plasma Lipids in Postmenopausal Women With Noninsulin-Dependent Diabetes Mellitus
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 638 - 643.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Association for Clinical Chemistry.